Murray Stahl’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Buy |
69,662
+712
| +1% | +$18.6K | 0.02% | 126 |
|
|
2026
Q1 | $1.94M | Buy |
68,950
+1,279
| +2% | +$34.1K | 0.02% | 123 |
|
|
2025
Q4 | $1.69M | Sell |
67,671
-3,155
| -4% | -$79.6K | 0.02% | 125 |
|
|
2025
Q3 | $1.8M | Sell |
70,826
-32,357
| -31% | -$799K | 0.02% | 125 |
|
|
2025
Q2 | $2.5M | Buy |
103,183
+3,157
| +3% | +$73.6K | 0.03% | 107 |
|
|
2025
Q1 | $2.53M | Sell |
100,026
-677
| -0.7% | -$17.7K | 0.03% | 106 |
|
|
2024
Q4 | $2.67M | Buy |
100,703
+6,888
| +7% | +$187K | 0.03% | 108 |
|
|
2024
Q3 | $2.72M | Buy |
93,815
+36,370
| +63% | +$1.06M | 0.04% | 103 |
|
|
2024
Q2 | $1.61M | Buy |
57,445
+300
| +0.5% | +$8.26K | 0.03% | 121 |
|
|
2024
Q1 | $1.59M | Buy |
57,145
+6,979
| +14% | +$194K | 0.03% | 119 |
|
|
2023
Q4 | $1.44M | Sell |
50,166
-255
| -0.5% | -$7.71K | 0.03% | 122 |
|
|
2023
Q3 | $1.67M | Buy |
50,421
+1,850
| +4% | +$65.4K | 0.03% | 109 |
|
|
2023
Q2 | $1.78M | Buy |
48,571
+209
| +0.4% | +$8.13K | 0.04% | 106 |
|
|
2023
Q1 | $1.97M | Sell |
48,362
-2,550
| -5% | -$110K | 0.04% | 99 |
|
|
2022
Q4 | $2.61M | Hold |
50,912
| – | – | 0.04% | 84 |
|
|
2022
Q3 | $2.23M | Sell |
50,912
-654
| -1% | -$31.8K | 0.04% | 89 |
|
|
2022
Q2 | $2.7M | Sell |
51,566
-1,940
| -4% | -$98.9K | 0.06% | 84 |
|
|
2022
Q1 | $2.77M | Hold |
53,506
| – | – | 0.06% | 97 |
|
|
2021
Q4 | $3.16M | Buy |
53,506
+189
| +0.4% | +$9.36K | 0.07% | 89 |
|
|
2021
Q3 | $2.29M | Sell |
53,317
-1,100
| -2% | -$48.7K | 0.05% | 108 |
|
|
2021
Q2 | $2.13M | Sell |
54,417
-3,268
| -6% | -$127K | 0.04% | 120 |
|
|
2021
Q1 | $2.09M | Buy |
57,685
+2,253
| +4% | +$80K | 0.05% | 118 |
|
|
2020
Q4 | $2.04M | Sell |
55,432
-11,030
| -17% | -$405K | 0.07% | 111 |
|
|
2020
Q3 | $2.31M | Buy |
66,462
+1,660
| +3% | +$58.2K | 0.09% | 100 |
|
|
2020
Q2 | $2.01M | Sell |
64,802
-3,945
| -6% | -$134K | 0.07% | 103 |
|
|
2020
Q1 | $2.13M | Buy |
68,747
+1,257
| +2% | +$42.8K | 0.09% | 84 |
|
|
2019
Q4 | $2.51M | Buy |
67,490
+2,064
| +3% | +$73.5K | 0.07% | 88 |
|
|
2019
Q3 | $2.23M | Sell |
65,426
-3,475
| -5% | -$126K | 0.07% | 102 |
|
|
2019
Q2 | $2.83M | Sell |
68,901
-1,199
| -2% | -$47.6K | 0.08% | 93 |
|
|
2019
Q1 | $2.83M | Buy |
+70,100
| New | +$2.81M | 0.08% | 94 |
|
Other funds holding PFE
Murray Stahl's PFE Position: Q2 2026 in Review
Murray Stahl increased its Pfizer (PFE) stake by 1% in Q2 2026, buying an estimated $18.6K and bringing the position to 69,662 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #126.
Murray Stahl first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.16M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Murray Stahl held 69,662 shares of Pfizer worth $1.68M as of Q2 2026.
- Murray Stahl bought 712 Pfizer shares in Q2 2026, an estimated $18.6K.
- Pfizer made up 0.02% of Murray Stahl's portfolio in Q2 2026, its #126 holding.
- Murray Stahl first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
- Murray Stahl's Pfizer position peaked at $3.16M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.